Aryee Lab: Martin J. Aryee, PhD
We develop statistical methods to improve our understanding of tumor cell-to-cell variability and its relationship to cancer progression.
Safe Care CommitmentGet the latest news on COVID-19, the vaccine and care at Mass General.Learn more
We develop statistical methods to improve our understanding of tumor cell-to-cell variability and its relationship to cancer progression.
Researching mucosal immunology and inflammatory bowel disease.
Leo L. Cheng, PhD
Robert B. Colvin, MD
dias-santagata-researchlab. dias-santagata-researchlab. Dias-Santagata Lab Targeted cancer therapies require the rapid and accurate identification of genetic abnormalities predictive of therapeutic response. Our lab developed the first
Anand S. Dighe, MD, PhD
Dr. Dryja is a principal investigator researching ophthalmic pathology, hereditary diseases of the eye, and new therapies for eye disease.
Matthew P. Frosch, MD, PhD
hariri-lab. hariri-lab. Hariri Lab - Lida P. Hariri, MD, PhD My overall research interests include: 1) the development and clinical application of highresolution optical imaging for early detection and diagnosis of pulmonary diseases, including
Herrmann-markus. Herrmann-markus. Markus D. Herrmann, MD, PhD Markus D. Herrmann, MD, PhD Assistant Professor of Pathology, Harvard Medical School Director of Computational Pathology, Massachusetts General Hospital Assistant Computational
Research at Massachusetts General Hospital integrates the full spectrum of "bench to bedside" discovery. Laboratory scientists work collaboratively with clinicians to make discoveries and turn them into treatments, diagnostics and devices that improve our quality of life.